| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.903 | 0.001 | 0.903 | Calcium antagonist | 0.538 0.002 DBMET01899 0.741 0.001 DBMET01901 0.389 0.003 DBMET01900 0.694 0.001 DBMET01902 0.322 0.004 DBMET01903 | ||
| 0.898 | 0.002 | 0.898 | Calcium channel blocker | 0.754 0.003 DBMET01899 0.77 0.003 DBMET01901 0.574 0.004 DBMET01900 0.731 0.003 DBMET01902 0.517 0.004 DBMET01903 | ||
| 0.849 | 0.003 | 0.849 | Vasodilator, coronary | 0.459 0.022 DBMET01899 0.766 0.004 DBMET01901 0.394 0.037 DBMET01900 0.821 0.004 DBMET01902 0.432 0.027 DBMET01903 | ||
| 0.813 | 0.004 | 0.829 | Vasodilator, peripheral | 0.576 0.018 DBMET01899 0.739 0.005 DBMET01901 0.449 0.041 DBMET01900 0.829 0.003 DBMET01902 0.609 0.015 DBMET01903 | DBMET01902 | |
| 0.758 | 0.003 | 0.758 | Calcium channel (voltage-sensitive) blocker | 0.526 0.004 DBMET01899 0.495 0.004 DBMET01901 0.307 0.006 DBMET01900 0.537 0.004 DBMET01902 0.326 0.005 DBMET01903 | ||
| 0.73 | 0.001 | 0.73 | Calcium channel L-type blocker | 0.513 0.002 DBMET01899 0.635 0.002 DBMET01901 0.432 0.003 DBMET01900 0.673 0.002 DBMET01902 0.457 0.003 DBMET01903 | ||
| 0.663 | 0.003 | 0.717 | Calcium channel L-type activator | 0.657 0.004 DBMET01899 0.676 0.003 DBMET01901 0.674 0.003 DBMET01900 0.717 0.002 DBMET01902 0.716 0.002 DBMET01903 | DBMET01902 | |
| 0.632 | 0.005 | 0.691 | Vasodilator | 0.366 0.029 DBMET01899 0.651 0.005 DBMET01901 0.391 0.025 DBMET01900 0.691 0.004 DBMET01902 0.395 0.024 DBMET01903 | DBMET01902 | |
| 0.59 | 0.003 | 0.673 | Calcium channel activator | 0.504 0.005 DBMET01899 0.623 0.002 DBMET01901 0.54 0.004 DBMET01900 0.673 0.002 DBMET01902 0.573 0.003 DBMET01903 | DBMET01902 | |
| 0.489 | 0.024 | 0.494 | Spasmolytic | 0.205 0.115 DBMET01899 0.494 0.024 DBMET01901 0.224 0.103 DBMET01900 0.214 0.109 DBMET01902 | DBMET01901 | |
| 0.457 | 0.02 | 0.494 | Cardiotonic | 0.245 0.086 DBMET01899 0.358 0.037 DBMET01901 0.494 0.016 DBMET01902 0.213 0.107 DBMET01903 | DBMET01902 | |
| 0.347 | 0.004 | 0.593 | TRPA1 agonist | 0.127 0.051 DBMET01899 0.233 0.006 DBMET01901 0.098 0.092 DBMET01900 0.593 0.003 DBMET01902 0.183 0.015 DBMET01903 | DBMET01902 | |
| 0.345 | 0.022 | 0.345 | P-glycoprotein inhibitor | 0.297 0.029 DBMET01899 0.294 0.03 DBMET01901 0.256 0.039 DBMET01900 0.211 0.058 DBMET01902 0.165 0.095 DBMET01903 | ||
| 0.328 | 0.032 | 0.448 | Cyclic AMP phosphodiesterase inhibitor | 0.164 0.13 DBMET01899 0.389 0.018 DBMET01901 0.203 0.091 DBMET01900 0.448 0.011 DBMET01902 0.264 0.057 DBMET01903 | DBMET01902 | |
| 0.291 | 0.036 | 0.291 | 5 Hydroxytryptamine 1E antagonist | 0.215 0.114 DBMET01899 0.238 0.087 DBMET01901 0.284 0.041 DBMET01902 0.204 0.127 DBMET01903 | ||
| 0.239 | 0.01 | 0.308 | Neuropeptide Y1 antagonist | 0.192 0.022 DBMET01899 0.22 0.013 DBMET01901 0.178 0.031 DBMET01900 0.308 0.005 DBMET01902 0.242 0.009 DBMET01903 | DBMET01902 | |
| 0.31 | 0.082 | 0.356 | Antithrombotic | 0.27 0.111 DBMET01901 0.356 0.062 DBMET01902 0.205 0.171 DBMET01903 | DBMET01902 | |
| 0.232 | 0.011 | 0.41 | Adenylate kinase inhibitor | 0.109 0.054 DBMET01899 0.244 0.01 DBMET01901 0.115 0.048 DBMET01900 0.41 0.003 DBMET01902 0.264 0.009 DBMET01903 | DBMET01902 | |
| 0.228 | 0.013 | 0.228 | Alpha 2c adrenoreceptor antagonist | 0.135 0.04 DBMET01899 0.15 0.032 DBMET01901 0.178 0.023 DBMET01902 0.103 0.063 DBMET01903 | ||
| 0.245 | 0.05 | 0.263 | Sigma receptor agonist | 0.263 0.046 DBMET01899 0.118 0.117 DBMET01900 0.205 0.06 DBMET01902 0.223 0.055 DBMET01903 | DBMET01899 | |
| 0.243 | 0.055 | 0.298 | Platelet aggregation inhibitor | 0.193 0.087 DBMET01901 0.298 0.036 DBMET01902 | DBMET01902 | |
| 0.207 | 0.022 | 0.236 | Alpha 2b adrenoreceptor antagonist | 0.11 0.066 DBMET01899 0.18 0.029 DBMET01901 0.09 0.085 DBMET01900 0.236 0.017 DBMET01902 0.129 0.051 DBMET01903 | DBMET01902 | |
| 0.225 | 0.085 | 0.285 | Platelet antagonist | 0.191 0.108 DBMET01901 0.285 0.058 DBMET01902 | DBMET01902 | |
| 0.203 | 0.078 | 0.203 | Psychostimulant | 0.199 0.081 DBMET01901 0.153 0.113 DBMET01902 | ||
| 0.138 | 0.024 | 0.138 | Alpha 1b adrenoreceptor antagonist | 0.068 0.054 DBMET01901 0.129 0.027 DBMET01902 | ||
| 0.11 | 0.013 | 0.11 | Calcium channel T-type blocker | |||
| 0.154 | 0.07 | 0.289 | CF transmembrane conductance regulator agonist | 0.208 0.018 DBMET01901 0.289 0.004 DBMET01902 0.17 0.047 DBMET01903 | DBMET01902 | |
| 0.088 | 0.01 | 0.088 | Nicotinic alpha3beta2 receptor antagonist | 0.078 0.014 DBMET01899 0.077 0.014 DBMET01901 0.071 0.017 DBMET01900 0.06 0.027 DBMET01902 0.054 0.034 DBMET01903 | ||
| 0.141 | 0.064 | 0.186 | Farnesoid X receptor antagonist | 0.13 0.082 DBMET01901 0.186 0.027 DBMET01902 | DBMET01902 | |
| 0.102 | 0.03 | 0.137 | Glycine receptor antagonist | 0.112 0.023 DBMET01901 0.137 0.011 DBMET01902 | DBMET01902 | |
| 0.073 | 0.013 | 0.176 | Aldosterone antagonist | 0.101 0.008 DBMET01901 0.176 0.004 DBMET01902 | DBMET01902 | |
| 0.129 | 0.07 | 0.14 | Acetylcholinesterase inhibitor | 0.14 0.062 DBMET01899 | DBMET01899 | |
| 0.075 | 0.019 | 0.075 | Dopamine transporter inhibitor | 0.045 0.037 DBMET01899 0.074 0.019 DBMET01901 0.045 0.037 DBMET01900 | ||
| 0.068 | 0.015 | 0.133 | Mineralocorticoid receptor antagonist | 0.074 0.013 DBMET01901 0.133 0.005 DBMET01902 | DBMET01902 | |
| 0.091 | 0.04 | 0.091 | Alpha 1a adrenoreceptor antagonist | |||
| 0.118 | 0.068 | 0.368 | Anesthetic local | 0.368 0.008 DBMET01899 0.309 0.012 DBMET01900 0.24 0.022 DBMET01903 | DBMET01899 | |
| 0.117 | 0.07 | 0.154 | Acetylcholine muscarinic antagonist | 0.154 0.041 DBMET01899 | DBMET01899 | |
| 0.135 | 0.09 | 0.136 | Cholinergic | 0.136 0.09 DBMET01899 | DBMET01899 | |
| 0.15 | 0.105 | 0.249 | Lipocortins synthesis antagonist | 0.163 0.088 DBMET01901 0.249 0.034 DBMET01902 0.171 0.079 DBMET01903 | DBMET01902 | |
| 0.086 | 0.044 | 0.086 | Nicotinic alpha4beta2 receptor antagonist | 0.072 0.06 DBMET01901 | ||
| 0.071 | 0.03 | 0.071 | Dopamine uptake inhibitor | |||
| 0.073 | 0.034 | 0.118 | Alpha 1d adrenoreceptor antagonist | 0.118 0.019 DBMET01902 | DBMET01902 | |
| 0.101 | 0.067 | 0.13 | Toll-Like receptor 4 antagonist | 0.107 0.059 DBMET01899 0.1 0.07 DBMET01901 0.11 0.055 DBMET01900 0.121 0.043 DBMET01902 0.13 0.035 DBMET01903 | DBMET01903 | |
| 0.129 | 0.096 | 0.156 | Acetylcholine M1 receptor antagonist | 0.156 0.069 DBMET01899 | DBMET01899 | |
| 0.111 | 0.079 | 0.147 | Acetylcholine antagonist | 0.147 0.051 DBMET01899 | DBMET01899 | |
| 0.113 | 0.081 | 0.151 | Cholinergic antagonist | 0.151 0.052 DBMET01899 | DBMET01899 | |
| 0.048 | 0.018 | 0.052 | Acid-sensing ion channel blocker | 0.052 0.015 DBMET01899 | DBMET01899 | |
| 0.076 | 0.047 | 0.076 | Histone deacetylase SIRT1 stimulant | 0.074 0.05 DBMET01902 | ||
| 0.076 | 0.047 | 0.076 | Histone deacetylase stimulant | 0.074 0.05 DBMET01902 | ||
| 0.067 | 0.038 | 0.077 | Nitric oxide donor | 0.067 0.037 DBMET01901 0.077 0.025 DBMET01902 | DBMET01902 | |
| 0.247 | 0.218 | 0.296 | Apoptosis agonist | 0.296 0.175 DBMET01899 0.264 0.201 DBMET01900 0.277 0.189 DBMET01903 | DBMET01899 | |
| 0.143 | 0.117 | 0.185 | Hepatoprotectant | 0.136 0.126 DBMET01901 0.185 0.075 DBMET01902 | DBMET01902 | |
| 0.079 | 0.053 | 0.079 | Alpha 1 adrenoreceptor antagonist | |||
| 0.076 | 0.052 | 0.076 | Alpha 2a adrenoreceptor antagonist | 0.076 0.052 DBMET01902 | ||
| 0.087 | 0.066 | 0.087 | Alpha adrenoreceptor antagonist | |||
| 0.083 | 0.062 | 0.195 | Androgen antagonist | 0.094 0.051 DBMET01901 0.195 0.014 DBMET01902 0.077 0.069 DBMET01903 | DBMET01902 | |
| 0.06 | 0.042 | 0.116 | Potassium channel intermediate-conductance Ca-activated blocker | 0.116 0.005 DBMET01902 0.078 0.019 DBMET01903 | DBMET01902 | |
| 0.057 | 0.048 | 0.084 | Acetylcholine M2 receptor antagonist | 0.084 0.027 DBMET01899 | DBMET01899 | |
| 0.08 | 0.071 | 0.082 | Antiadrenergic | 0.082 0.069 DBMET01902 | DBMET01902 | |
| 0.181 | 0.177 | 0.287 | Hypoxia-inducible factor 1 alpha inhibitor | 0.287 0.072 DBMET01902 0.274 0.08 DBMET01903 | DBMET01902 | |
| 0.076 | 0.072 | 0.08 | Adrenaline antagonist | 0.08 0.068 DBMET01902 | DBMET01902 | |
| 0.031 | 0.029 | 0.043 | Transforming growth factor beta 2 antagonist | 0.033 0.024 DBMET01901 0.043 0.01 DBMET01902 | DBMET01902 | |
| 0.06 | 0.058 | 0.093 | Calcium channel P-type blocker | 0.093 0.008 DBMET01899 0.066 0.038 DBMET01903 | DBMET01899 | |
| 0.122 | 0.122 | 0.14 | Pregnane X receptor agonist | 0.14 0.074 DBMET01902 | DBMET01902 | |
| 0.117 | 0.12 | 0.168 | NOS3 expression enhancer | 0.161 0.062 DBMET01902 0.168 0.057 DBMET01903 | DBMET01903 | |
| 0.208 | 0.215 | 0.397 | Alpha-glucosidase inhibitor | 0.283 0.169 DBMET01899 0.313 0.153 DBMET01902 0.397 0.116 DBMET01903 | DBMET01903 | |
| 0.077 | 0.086 | 0.23 | Breast cancer-resistant protein inhibitor | 0.154 0.022 DBMET01899 0.154 0.022 DBMET01900 0.094 0.062 DBMET01902 0.23 0.011 DBMET01903 | DBMET01903 | |
| 0.103 | 0.113 | 0.196 | Interleukin 4 antagonist | 0.146 0.054 DBMET01899 0.141 0.058 DBMET01900 0.136 0.064 DBMET01902 0.196 0.023 DBMET01903 | DBMET01903 | |
| 0.125 | 0.138 | 0.247 | Platelet adhesion inhibitor | 0.247 0.05 DBMET01899 0.169 0.089 DBMET01900 0.19 0.077 DBMET01903 | DBMET01899 | |
| 0.047 | 0.06 | 0.063 | Acetylcholine M3 receptor antagonist | 0.063 0.038 DBMET01899 | DBMET01899 | |
| 0.134 | 0.148 | 0.147 | Death-associated protein kinase 2 inhibitor | 0.147 0.114 DBMET01902 | DBMET01902 | |
| 0.042 | 0.059 | 0.05 | Protein kinase C eta inhibitor | 0.05 0.044 DBMET01899 | DBMET01899 | |
| 0.052 | 0.071 | 0.082 | Bcl2 antagonist | 0.082 0.03 DBMET01899 0.082 0.03 DBMET01903 | DBMET01903 | |
| 0.076 | 0.11 | 0.131 | Bile acid receptor antagonist | 0.131 0.013 DBMET01902 0.087 0.082 DBMET01903 | DBMET01902 | |
| 0.132 | 0.173 | 0.201 | Free radical scavenger | 0.201 0.097 DBMET01902 0.184 0.111 DBMET01903 | DBMET01902 | |
| 0.02 | 0.062 | 0.042 | Catechol O-methyltransferase inhibitor | 0.03 0.027 DBMET01902 0.042 0.013 DBMET01903 | DBMET01903 | |
| 0.016 | 0.059 | 0.073 | NMDA 2D receptor antagonist | 0.054 0.006 DBMET01902 0.073 0.005 DBMET01903 | DBMET01903 | |
| 0.024 | 0.076 | 0.117 | Phosphorylase inhibitor | 0.117 0.01 DBMET01902 0.046 0.033 DBMET01903 | DBMET01902 | |
| 0.077 | 0.13 | 0.134 | Multidrug resistance-associated protein 1 inhibitor | 0.102 0.074 DBMET01899 0.1 0.078 DBMET01902 0.134 0.035 DBMET01903 | DBMET01903 | |
| 0.13 | 0.192 | 0.186 | Antioxidant | 0.186 0.126 DBMET01902 | DBMET01902 | |
| 0.02 | 0.083 | 0.037 | Purinergic P2Y2 antagonist | 0.032 0.026 DBMET01902 0.037 0.019 DBMET01903 | DBMET01903 | |
| 0.059 | 0.124 | 0.124 | Mediator release inhibitor | 0.124 0.044 DBMET01902 | DBMET01902 | |
| 0.105 | 0.17 | 0.167 | Amyloid beta precursor protein antagonist | 0.167 0.084 DBMET01902 0.166 0.084 DBMET01903 | DBMET01902 | |
| 0.093 | 0.16 | 0.184 | Phospholipase A2 inhibitor | 0.184 0.052 DBMET01902 0.146 0.078 DBMET01903 | DBMET01902 | |
| 0.071 | 0.138 | 0.129 | Beta glucuronidase inhibitor | 0.129 0.038 DBMET01902 0.12 0.046 DBMET01903 | DBMET01902 | |
| 0.079 | 0.147 | 0.096 | Factor V inhibitor | 0.096 0.08 DBMET01903 | DBMET01903 | |
| 0.045 | 0.114 | 0.06 | Ryanodine receptor antagonist | 0.06 0.038 DBMET01903 | DBMET01903 | |
| 0.056 | 0.127 | 0.086 | Neuropeptide Y antagonist | 0.086 0.051 DBMET01902 | DBMET01902 | |
| 0.064 | 0.135 | 0.081 | Thioredoxin inhibitor | 0.081 0.08 DBMET01902 0.081 0.079 DBMET01903 | DBMET01903 | |
| 0.12 | 0.198 | 0.179 | Catenin beta inhibitor | 0.157 0.09 DBMET01902 0.179 0.054 DBMET01903 | DBMET01903 | |
| 0.062 | 0.144 | 0.107 | Thioredoxin reductase inhibitor | 0.087 0.047 DBMET01902 0.107 0.023 DBMET01903 | DBMET01903 | |
| 0.024 | 0.106 | 0.081 | Glutamate (mGluR1) antagonist | 0.063 0.036 DBMET01902 0.081 0.023 DBMET01903 | DBMET01903 | |
| 0.037 | 0.123 | 0.079 | DNA gyrase inhibitor | 0.079 0.027 DBMET01902 | DBMET01902 | |
| 0.146 | 0.232 | 0.352 | Transcription factor NF kappa B inhibitor | 0.234 0.139 DBMET01901 0.352 0.076 DBMET01902 0.266 0.116 DBMET01903 | DBMET01902 | |
| 0.005 | 0.095 | 0.021 | Angiotensin AT1A receptor antagonist | 0.021 0.019 DBMET01903 | DBMET01903 | |
| 0.051 | 0.143 | 0.088 | Viral attachment inhibitor | 0.088 0.035 DBMET01899 | DBMET01899 | |
| 0.014 | 0.108 | 0.03 | Epoxide hydrolase 1 inhibitor | 0.03 0.024 DBMET01902 | DBMET01902 | |
| 0.159 | 0.254 | 0.61 | Apoptosis antagonist | 0.606 0.009 DBMET01901 0.61 0.009 DBMET01900 0.244 0.134 DBMET01902 | DBMET01900 | |
| 0.076 | 0.174 | 0.129 | Toll-Like receptor antagonist | 0.129 0.073 DBMET01899 0.11 0.102 DBMET01903 | DBMET01899 | |
| 0.042 | 0.142 | 0.065 | Bcl-xL inhibitor | 0.065 0.028 DBMET01903 | DBMET01903 | |
| 0.041 | 0.142 | 0.074 | Interferon inducer | 0.074 0.03 DBMET01903 | DBMET01903 | |
| 0.136 | 0.238 | 0.276 | Thioredoxin glutathione reductase inhibitor | 0.276 0.117 DBMET01902 0.263 0.126 DBMET01903 | DBMET01902 | |
| 0.032 | 0.136 | 0.091 | Thromboxane synthase inhibitor | 0.091 0.008 DBMET01902 0.07 0.017 DBMET01903 | DBMET01902 | |
| 0.1 | 0.208 | 0.169 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.169 0.043 DBMET01902 0.156 0.062 DBMET01903 | DBMET01902 | |
| 0.101 | 0.212 | 0.297 | Non-steroidal antiinflammatory agent | 0.257 0.04 DBMET01902 0.297 0.029 DBMET01903 | DBMET01903 | |
| 0.05 | 0.164 | 0.075 | MDM2 inhibitor | 0.075 0.027 DBMET01902 0.075 0.026 DBMET01903 | DBMET01903 | |
| 0.008 | 0.122 | 0.064 | Progesterone antagonist | 0.064 0.013 DBMET01902 | DBMET01902 | |
| 0.059 | 0.175 | 0.101 | Amylase inhibitor | 0.101 0.095 DBMET01902 | DBMET01902 | |
| 0.027 | 0.144 | 0.062 | Potassium channel (ATP-sensitive) activator | 0.062 0.015 DBMET01902 | DBMET01902 | |
| 0.028 | 0.147 | 0.065 | Potassium channel (Inward rectifier) activator | 0.065 0.015 DBMET01902 | DBMET01902 | |
| 0.056 | 0.181 | 0.103 | ABCA1 expression enhancer | 0.103 0.046 DBMET01902 | DBMET01902 | |
| 0.025 | 0.152 | 0.049 | DNA gyrase subunit A inhibitor | 0.049 0.019 DBMET01903 | DBMET01903 | |
| 0.016 | 0.144 | 0.075 | Thromboxane A2 antagonist | 0.075 0.018 DBMET01902 0.045 0.04 DBMET01903 | DBMET01902 | |
| 0.055 | 0.183 | 0.125 | Interleukin 5 antagonist | 0.093 0.05 DBMET01902 0.125 0.021 DBMET01903 | DBMET01903 | |
| 0.041 | 0.169 | 0.086 | Adenosine A3 receptor antagonist | 0.086 0.036 DBMET01902 | DBMET01902 | |
| 0.084 | 0.214 | 0.264 | Anesthetic general | 0.214 0.067 DBMET01902 0.264 0.044 DBMET01903 | DBMET01903 | |
| 0.019 | 0.15 | 0.082 | Thromboxane antagonist | 0.082 0.019 DBMET01902 0.055 0.036 DBMET01903 | DBMET01902 | |
| 0.145 | 0.278 | 0.31 | Sodium/bile acid cotransporter inhibitor | 0.271 0.106 DBMET01902 0.31 0.071 DBMET01903 | DBMET01903 | |
| 0.129 | 0.263 | 0.191 | Peptidyltransferase inhibitor | 0.191 0.111 DBMET01902 | DBMET01902 | |
| 0.143 | 0.279 | 0.497 | DNA polymerase beta inhibitor | 0.412 0.114 DBMET01902 0.497 0.088 DBMET01903 | DBMET01903 | |
| 0.039 | 0.177 | 0.089 | Interferon agonist | 0.089 0.04 DBMET01903 | DBMET01903 | |
| 0.041 | 0.191 | 0.108 | Potassium channel activator | 0.108 0.041 DBMET01902 | DBMET01902 | |
| 0.03 | 0.18 | 0.093 | Beta adrenoreceptor antagonist | 0.093 0.019 DBMET01902 | DBMET01902 | |
| 0.073 | 0.227 | 0.136 | Sphingosine 1-phosphate receptor 4 antagonist | 0.136 0.048 DBMET01902 0.136 0.048 DBMET01903 | DBMET01903 | |
| 0.013 | 0.169 | 0.038 | Integrin alpha5beta1 antagonist | 0.037 0.034 DBMET01901 0.038 0.032 DBMET01900 | DBMET01900 | |
| 0.051 | 0.209 | 0.184 | Alkylator | 0.101 0.087 DBMET01900 0.146 0.049 DBMET01902 0.184 0.031 DBMET01903 | DBMET01903 | |
| 0.059 | 0.217 | 0.255 | Cytidine deaminase inhibitor | 0.121 0.099 DBMET01899 0.154 0.072 DBMET01900 0.153 0.073 DBMET01902 0.255 0.028 DBMET01903 | DBMET01903 | |
| 0.003 | 0.167 | 0.017 | Angiotensin AT1B receptor antagonist | 0.017 0.007 DBMET01903 | DBMET01903 | |
| 0.035 | 0.201 | 0.091 | Protein-tyrosine phosphatase 1B inhibitor | 0.091 0.088 DBMET01903 | DBMET01903 | |
| 0.067 | 0.241 | 0.273 | Diuretic | 0.273 0.027 DBMET01902 | DBMET01902 | |
| 0.048 | 0.223 | 0.088 | Phosphodiesterase 7B inhibitor | 0.088 0.073 DBMET01903 | DBMET01903 | |
| 0.012 | 0.188 | 0.059 | Angiotensin II receptor antagonist | 0.032 0.028 DBMET01899 0.059 0.005 DBMET01903 | DBMET01903 | |
| 0.034 | 0.211 | 0.079 | Potassium channel large-conductance Ca-activated activator | 0.079 0.036 DBMET01903 | DBMET01903 | |
| 0.013 | 0.192 | 0.066 | NMDA 2C receptor antagonist | 0.066 0.037 DBMET01902 0.062 0.042 DBMET01903 | DBMET01902 | |
| 0.023 | 0.206 | 0.067 | Neuraminidase (influenza) inhibitor | 0.067 0.039 DBMET01903 | DBMET01903 | |
| 0.015 | 0.2 | 0.061 | Neuraminidase inhibitor | 0.061 0.042 DBMET01903 | DBMET01903 | |
| 0.11 | 0.297 | 0.226 | Gastrin inhibitor | 0.226 0.11 DBMET01902 0.198 0.152 DBMET01903 | DBMET01902 | |
| 0.058 | 0.246 | 0.262 | Mcl-1 antagonist | 0.189 0.062 DBMET01902 0.262 0.032 DBMET01903 | DBMET01903 | |
| 0.04 | 0.228 | 0.117 | HIV-1 integrase (Overall Integration) inhibitor | 0.117 0.041 DBMET01902 0.099 0.056 DBMET01903 | DBMET01902 | |
| 0.12 | 0.312 | 0.449 | DNA directed DNA polymerase inhibitor | 0.372 0.128 DBMET01902 0.449 0.098 DBMET01903 | DBMET01903 | |
| 0.018 | 0.215 | 0.071 | Beta 1 adrenoreceptor antagonist | 0.071 0.025 DBMET01902 | DBMET01902 | |
| 0.018 | 0.215 | 0.067 | Glutamate (mGluR8) agonist | 0.066 0.005 DBMET01902 0.067 0.005 DBMET01903 | DBMET01903 | |
| 0.073 | 0.274 | 0.169 | DNA methylase inhibitor | 0.169 0.101 DBMET01903 | DBMET01903 | |
| 0.194 | 0.395 | 0.319 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.319 0.188 DBMET01902 0.274 0.25 DBMET01903 | DBMET01902 | |
| 0.018 | 0.223 | 0.067 | HIV-1 integrase (3'-Processing) inhibitor | 0.067 0.041 DBMET01903 | DBMET01903 | |
| 0.067 | 0.284 | 0.175 | Interleukin agonist | 0.164 0.154 DBMET01902 0.175 0.144 DBMET01903 | DBMET01903 | |
| 0.028 | 0.247 | 0.167 | Potassium channel (Ca-activated) activator | 0.11 0.048 DBMET01902 0.167 0.023 DBMET01903 | DBMET01903 | |
| 0.048 | 0.271 | 0.153 | Protein-tyrosine phosphatase inhibitor | 0.131 0.1 DBMET01902 0.153 0.075 DBMET01903 | DBMET01903 | |
| 0.013 | 0.236 | 0.049 | Retinoic acid alpha receptor agonist | 0.038 0.028 DBMET01902 0.049 0.015 DBMET01903 | DBMET01903 | |
| 0.009 | 0.242 | 0.063 | Angiotensin AT1 receptor antagonist | 0.063 0.005 DBMET01903 | DBMET01903 | |
| 0.033 | 0.267 | 0.109 | Cholesterol synthesis inhibitor | 0.109 0.076 DBMET01903 | DBMET01903 | |
| 0.127 | 0.367 | 0.208 | Interleukin 2 agonist | 0.208 0.176 DBMET01902 | DBMET01902 | |
| 0.039 | 0.279 | 0.089 | GABA B receptor agonist | 0.089 0.028 DBMET01902 0.089 0.027 DBMET01903 | DBMET01903 | |
| 0.074 | 0.319 | 0.163 | Interferon gamma antagonist | 0.163 0.063 DBMET01902 0.163 0.063 DBMET01903 | DBMET01903 | |
| 0.013 | 0.268 | 0.052 | Plasminogen activator inhibitor antagonist | 0.052 0.031 DBMET01903 | DBMET01903 | |
| 0.06 | 0.315 | 0.228 | DNA methyltransferase I inhibitor | 0.142 0.112 DBMET01902 0.228 0.056 DBMET01903 | DBMET01903 | |
| 0.094 | 0.35 | 0.38 | Cholesterol antagonist | 0.324 0.077 DBMET01902 0.38 0.054 DBMET01903 | DBMET01903 | |
| 0.007 | 0.263 | 0.019 | Retinoic acid beta receptor agonist | 0.019 0.015 DBMET01903 | DBMET01903 | |
| 0.073 | 0.333 | 0.206 | Beta lactamase inhibitor | 0.206 0.181 DBMET01903 | DBMET01903 | |
| 0.029 | 0.29 | 0.063 | Adenine nucleotide translocase inhibitor | 0.058 0.033 DBMET01902 0.063 0.024 DBMET01903 | DBMET01903 | |
| 0.02 | 0.281 | 0.087 | Glutamate (mGluR group III) antagonist | 0.087 0.006 DBMET01902 0.066 0.01 DBMET01903 | DBMET01902 | |
| 0.046 | 0.313 | 0.149 | Photosensitizer | 0.123 0.053 DBMET01902 0.149 0.032 DBMET01903 | DBMET01903 | |
| 0.023 | 0.293 | 0.12 | Chemokine receptor antagonist | 0.12 0.048 DBMET01900 | DBMET01900 | |
| 0.006 | 0.279 | 0.034 | NMDA receptor subunit 3A antagonist | 0.034 0.031 DBMET01902 | DBMET01902 | |
| 0.098 | 0.371 | 0.227 | RNA-directed DNA polymerase inhibitor | 0.225 0.069 DBMET01902 0.227 0.067 DBMET01903 | DBMET01903 | |
| 0.023 | 0.3 | 0.122 | Purinergic P2X1 antagonist | 0.058 0.046 DBMET01902 0.122 0.011 DBMET01903 | DBMET01903 | |
| 0.004 | 0.287 | 0.051 | Kainate receptor antagonist | 0.051 0.02 DBMET01902 0.046 0.024 DBMET01903 | DBMET01902 | |
| 0.022 | 0.307 | 0.153 | M18 aspartyl aminopeptidase inhibitor | 0.118 0.072 DBMET01902 0.153 0.05 DBMET01903 | DBMET01903 | |
| 0.031 | 0.317 | 0.08 | Glutamate (mGluR6) antagonist | 0.08 0.024 DBMET01902 0.072 0.036 DBMET01903 | DBMET01902 | |
| 0.016 | 0.304 | 0.265 | Histidine decarboxylase inhibitor | 0.191 0.014 DBMET01902 0.265 0.008 DBMET01903 | DBMET01903 | |
| 0.009 | 0.3 | 0.044 | NMDA receptor subunit 3B antagonist | 0.044 0.03 DBMET01902 0.04 0.035 DBMET01903 | DBMET01902 | |
| 0.016 | 0.309 | 0.078 | NMDA receptor antagonist | 0.078 0.068 DBMET01902 | DBMET01902 | |
| 0.003 | 0.297 | 0.042 | NMDA receptor glycine site antagonist | 0.042 0.008 DBMET01902 0.025 0.016 DBMET01903 | DBMET01902 | |
| 0.035 | 0.33 | 0.157 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.157 0.024 DBMET01902 0.139 0.03 DBMET01903 | DBMET01902 | |
| 0.099 | 0.396 | 0.149 | Heat shock protein 70 antagonist | 0.149 0.048 DBMET01902 0.149 0.047 DBMET01903 | DBMET01903 | |
| 0.006 | 0.307 | 0.036 | DNA gyrase subunit B inhibitor | 0.036 0.03 DBMET01903 | DBMET01903 | |
| 0.013 | 0.322 | 0.055 | AICAR transformylase inhibitor | 0.045 0.029 DBMET01902 0.055 0.018 DBMET01903 | DBMET01903 | |
| 0.011 | 0.321 | 0.069 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.069 0.031 DBMET01903 | DBMET01903 | |
| 0.04 | 0.356 | 0.206 | DOPA decarboxylase inhibitor | 0.163 0.015 DBMET01902 0.206 0.006 DBMET01903 | DBMET01903 | |
| 0.071 | 0.39 | 0.133 | Sphingosine 1-phosphate receptor 5 antagonist | 0.133 0.093 DBMET01902 0.127 0.107 DBMET01903 | DBMET01902 | |
| 0.009 | 0.328 | 0.077 | Nerve growth factor antagonist | 0.041 0.034 DBMET01902 0.077 0.004 DBMET01903 | DBMET01903 | |
| 0.017 | 0.341 | 0.072 | Glutamate (mGluR4) antagonist | 0.072 0.01 DBMET01902 0.058 0.015 DBMET01903 | DBMET01902 | |
| 0.011 | 0.339 | 0.134 | Biliverdin reductase inhibitor | 0.102 0.018 DBMET01902 0.134 0.011 DBMET01903 | DBMET01903 | |
| 0.02 | 0.352 | 0.162 | M17 leucyl aminopeptidase inhibitor | 0.146 0.058 DBMET01902 0.162 0.049 DBMET01903 | DBMET01903 | |
| 0.024 | 0.363 | 0.058 | DNA helicase inhibitor | 0.058 0.031 DBMET01903 | DBMET01903 | |
| 0.001 | 0.339 | 0.006 | Insulin like growth factor 3 antagonist | 0.006 0.004 DBMET01903 | DBMET01903 | |
| 0.04 | 0.387 | 0.112 | Interleukin 1 antagonist | 0.112 0.1 DBMET01903 | DBMET01903 | |
| 0.033 | 0.38 | 0.134 | Cathepsin H inhibitor | 0.116 0.08 DBMET01902 0.134 0.06 DBMET01903 | DBMET01903 | |
| 0.078 | 0.428 | 0.302 | Transcription factor inhibitor | 0.286 0.163 DBMET01902 0.302 0.153 DBMET01903 | DBMET01903 | |
| 0.065 | 0.425 | 0.264 | Transcription factor STAT3 inhibitor | 0.264 0.073 DBMET01902 0.193 0.144 DBMET01903 | DBMET01902 | |
| 0.021 | 0.383 | 0.11 | CD45 antagonist | 0.063 0.019 DBMET01902 0.11 0.008 DBMET01903 | DBMET01903 | |
| 0.017 | 0.38 | 0.072 | Glutamate (mGluR) antagonist | 0.072 0.058 DBMET01903 | DBMET01903 | |
| 0.014 | 0.379 | 0.038 | Kainate receptor agonist | 0.038 0.037 DBMET01902 | DBMET01902 | |
| 0.08 | 0.448 | 0.35 | Antibacterial | 0.32 0.12 DBMET01902 0.35 0.102 DBMET01903 | DBMET01903 | |
| 0.035 | 0.404 | 0.214 | Dual specificity phosphatase inhibitor | 0.138 0.109 DBMET01902 0.214 0.048 DBMET01903 | DBMET01903 | |
| 0.018 | 0.388 | 0.072 | HIV-1 integrase inhibitor | 0.072 0.045 DBMET01903 | DBMET01903 | |
| 0.024 | 0.394 | 0.151 | UDP-glucose 4-epimerase inhibitor | 0.13 0.037 DBMET01902 0.151 0.028 DBMET01903 | DBMET01903 | |
| 0.025 | 0.395 | 0.095 | Glutathione S-transferase inhibitor | 0.092 0.045 DBMET01902 0.095 0.042 DBMET01903 | DBMET01903 | |
| 0.052 | 0.424 | 0.151 | 3C-like protease (Human coronavirus) inhibitor | 0.151 0.099 DBMET01903 | DBMET01903 | |
| 0.004 | 0.378 | 0.027 | AMPA 3 receptor antagonist | 0.027 0.023 DBMET01903 | DBMET01903 | |
| 0.019 | 0.392 | 0.16 | Glutamate receptor antagonist | 0.16 0.044 DBMET01903 | DBMET01903 | |
| 0.035 | 0.422 | 0.197 | NADPH oxidase inhibitor | 0.197 0.036 DBMET01903 | DBMET01903 | |
| 0.003 | 0.391 | 0.073 | Kynurenine 3 monooxygenase inhibitor | 0.035 0.012 DBMET01902 0.073 0.004 DBMET01903 | DBMET01903 | |
| 0.028 | 0.417 | 0.216 | Xanthine oxidase inhibitor | 0.141 0.038 DBMET01902 0.216 0.016 DBMET01903 | DBMET01903 | |
| 0.051 | 0.442 | 0.318 | DNA damaging | 0.179 0.135 DBMET01900 0.318 0.05 DBMET01903 | DBMET01903 | |
| 0.008 | 0.405 | 0.053 | Carbonic anhydrase XIV inhibitor | 0.053 0.03 DBMET01903 | DBMET01903 | |
| 0.111 | 0.511 | 0.484 | Caspase 9 stimulant | 0.273 0.225 DBMET01900 0.307 0.186 DBMET01902 0.484 0.066 DBMET01903 | DBMET01903 | |
| 0.031 | 0.431 | 0.255 | Dual specificity phosphatase 3 inhibitor | 0.15 0.096 DBMET01902 0.255 0.039 DBMET01903 | DBMET01903 | |
| 0.066 | 0.474 | 0.222 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.199 0.073 DBMET01902 0.222 0.057 DBMET01903 | DBMET01903 | |
| 0.027 | 0.435 | 0.154 | Triose-phosphate isomerase inhibitor | 0.12 0.032 DBMET01902 0.154 0.019 DBMET01903 | DBMET01903 | |
| 0.015 | 0.425 | 0.113 | GABA aminotransferase inhibitor | 0.105 0.024 DBMET01902 0.113 0.019 DBMET01903 | DBMET01903 | |
| 0.01 | 0.425 | 0.099 | Sphingosine 1-phosphate receptor 4 agonist | 0.099 0.025 DBMET01903 | DBMET01903 | |
| 0.03 | 0.448 | 0.256 | Mannose-6-phosphate isomerase inhibitor | 0.2 0.031 DBMET01902 0.256 0.011 DBMET01903 | DBMET01903 | |
| 0.056 | 0.474 | 0.244 | 15-Lipoxygenase inhibitor | 0.234 0.178 DBMET01902 0.244 0.17 DBMET01903 | DBMET01903 | |
| 0.011 | 0.436 | 0.099 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.081 0.05 DBMET01902 0.099 0.038 DBMET01903 | DBMET01903 | |
| 0.009 | 0.438 | 0.057 | GABA B receptor antagonist | 0.057 0.014 DBMET01903 | DBMET01903 | |
| 0.039 | 0.472 | 0.282 | Streptokinase A inhibitor | 0.181 0.146 DBMET01902 0.282 0.087 DBMET01903 | DBMET01903 | |
| 0.031 | 0.465 | 0.128 | Heat shock protein 90 alpha antagonist | 0.128 0.114 DBMET01903 | DBMET01903 | |
| 0.007 | 0.441 | 0.118 | Alcohol oxidase inhibitor | 0.069 0.029 DBMET01902 0.118 0.014 DBMET01903 | DBMET01903 | |
| 0.043 | 0.485 | 0.341 | 12-Lipoxygenase inhibitor | 0.224 0.126 DBMET01902 0.341 0.06 DBMET01903 | DBMET01903 | |
| 0.056 | 0.499 | 0.201 | Hypoglycemic | 0.201 0.112 DBMET01903 | DBMET01903 | |
| 0.064 | 0.51 | 0.151 | Neurotensin receptor agonist | 0.151 0.098 DBMET01902 0.139 0.133 DBMET01903 | DBMET01902 | |
| 0.044 | 0.49 | 0.208 | Thyroid hormone beta antagonist | 0.208 0.147 DBMET01903 | DBMET01903 | |
| 0.027 | 0.475 | 0.064 | Transcription factor RelA inhibitor | 0.064 0.044 DBMET01903 | DBMET01903 | |
| 0.008 | 0.465 | 0.1 | Monophenol monooxygenase inhibitor | 0.1 0.076 DBMET01903 | DBMET01903 | |
| 0.02 | 0.479 | 0.078 | Keratolytic | 0.078 0.052 DBMET01902 0.071 0.063 DBMET01903 | DBMET01902 | |
| 0.007 | 0.469 | 0.05 | Argininosuccinate synthase inhibitor | 0.05 0.047 DBMET01903 | DBMET01903 | |
| 0.083 | 0.547 | 0.18 | Nitric-oxide synthase stimulant | 0.18 0.128 DBMET01902 0.177 0.134 DBMET01903 | DBMET01902 | |
| 0.078 | 0.544 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.131 0.113 DBMET01902 0.13 0.118 DBMET01903 | DBMET01902 | |
| 0.08 | 0.546 | 0.123 | CC chemokine 6 receptor antagonist | 0.123 0.104 DBMET01903 | DBMET01903 | |
| 0.04 | 0.507 | 0.225 | Thyroid hormone antagonist | 0.225 0.141 DBMET01903 | DBMET01903 | |
| 0.048 | 0.519 | 0.199 | Transcription factor STAT inhibitor | 0.199 0.14 DBMET01902 | DBMET01902 | |
| 0.025 | 0.501 | 0.4 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.316 0.06 DBMET01902 0.4 0.038 DBMET01903 | DBMET01903 | |
| 0.01 | 0.486 | 0.335 | CXC chemokine 4 receptor antagonist | 0.284 0.005 DBMET01901 0.335 0.004 DBMET01900 | DBMET01900 | |
| 0.02 | 0.497 | 0.11 | Uric acid excretion stimulant | 0.11 0.045 DBMET01903 | DBMET01903 | |
| 0.003 | 0.491 | 0.067 | AMPA receptor antagonist | 0.067 0.022 DBMET01903 | DBMET01903 | |
| 0.015 | 0.505 | 0.076 | Ornithine decarboxylase inhibitor | 0.076 0.071 DBMET01903 | DBMET01903 | |
| 0.014 | 0.505 | 0.07 | Macrophage migration inhibitory factor inhibitor | 0.07 0.066 DBMET01903 | DBMET01903 | |
| 0.041 | 0.533 | 0.125 | DNA repair enzyme inhibitor | 0.125 0.062 DBMET01903 | DBMET01903 | |
| 0.003 | 0.498 | 0.063 | Urate transporter 1 inhibitor | 0.063 0.013 DBMET01903 | DBMET01903 | |
| 0.025 | 0.523 | 0.146 | Aldehyde dehydrogenase inhibitor | 0.104 0.091 DBMET01902 0.146 0.05 DBMET01903 | DBMET01903 | |
| 0.012 | 0.511 | 0.098 | Urease inhibitor | 0.098 0.069 DBMET01902 0.098 0.07 DBMET01903 | DBMET01903 | |
| 0.017 | 0.52 | 0.194 | Alkaline phosphatase inhibitor | 0.117 0.09 DBMET01902 0.194 0.035 DBMET01903 | DBMET01903 | |
| 0.005 | 0.507 | 0.019 | Integrin beta6 antagonist | 0.019 0.004 DBMET01901 0.019 0.004 DBMET01900 | DBMET01900 | |
| 0.015 | 0.518 | 0.062 | Dihydroorotate oxidase inhibitor | 0.062 0.026 DBMET01902 0.061 0.028 DBMET01903 | DBMET01902 | |
| 0.005 | 0.51 | 0.07 | NMDA receptor glycine site agonist | 0.07 0.036 DBMET01902 0.068 0.038 DBMET01903 | DBMET01902 | |
| 0.005 | 0.51 | 0.07 | Prostaglandin-E synthase inhibitor | 0.07 0.049 DBMET01903 | DBMET01903 | |
| 0.003 | 0.509 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | 0.041 0.037 DBMET01902 0.05 0.024 DBMET01903 | DBMET01903 | |
| 0.031 | 0.538 | 0.229 | DNA synthesis inhibitor | 0.221 0.094 DBMET01902 0.229 0.083 DBMET01903 | DBMET01903 | |
| 0.019 | 0.53 | 0.111 | Alpha-N-acetylglucosaminidase inhibitor | 0.111 0.087 DBMET01903 | DBMET01903 | |
| 0.005 | 0.522 | 0.066 | Phosphofructokinase-1 inhibitor | 0.066 0.051 DBMET01903 | DBMET01903 | |
| 0.033 | 0.551 | 0.183 | GABA C receptor rho-2 antagonist | 0.136 0.094 DBMET01902 0.183 0.04 DBMET01903 | DBMET01903 | |
| 0.016 | 0.535 | 0.099 | Caspase 3 inhibitor | 0.099 0.094 DBMET01903 | DBMET01903 | |
| 0.013 | 0.535 | 0.084 | Carbonic anhydrase XIII inhibitor | 0.084 0.047 DBMET01903 | DBMET01903 | |
| 0.034 | 0.555 | 0.205 | Calpain 2 inhibitor | 0.205 0.183 DBMET01902 | DBMET01902 | |
| 0.029 | 0.553 | 0.109 | D-Ala-D-Ala ligase inhibitor | 0.095 0.035 DBMET01902 0.109 0.02 DBMET01903 | DBMET01903 | |
| 0.002 | 0.527 | 0.064 | Retinoid X receptor agonist | 0.064 0.012 DBMET01903 | DBMET01903 | |
| 0.02 | 0.545 | 0.246 | Prostaglandin dehydrogenase inhibitor | 0.246 0.128 DBMET01903 | DBMET01903 | |
| 0.014 | 0.54 | 0.491 | Aryl hydrocarbon receptor agonist | 0.201 0.102 DBMET01902 0.491 0.025 DBMET01903 | DBMET01903 | |
| 0.01 | 0.536 | 0.06 | NMDA receptor agonist | 0.06 0.047 DBMET01902 | DBMET01902 | |
| 0.006 | 0.533 | 0.11 | Xanthine dehydrogenase inhibitor | 0.11 0.013 DBMET01903 | DBMET01903 | |
| 0.003 | 0.532 | 0.043 | TRPM8 blocker | 0.043 0.022 DBMET01903 | DBMET01903 | |
| 0.023 | 0.565 | 0.083 | Granulocyte macrophage colony stimulating factor agonist | 0.083 0.067 DBMET01903 | DBMET01903 | |
| 0.034 | 0.579 | 0.157 | Phospholipase C inhibitor | 0.149 0.108 DBMET01902 0.157 0.094 DBMET01903 | DBMET01903 | |
| 0.01 | 0.556 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | 0.072 0.049 DBMET01903 | DBMET01903 | |
| 0.044 | 0.593 | 0.403 | Histamine release inhibitor | 0.278 0.136 DBMET01902 0.403 0.074 DBMET01903 | DBMET01903 | |
| 0.025 | 0.575 | 0.233 | Succinate dehydrogenase inhibitor | 0.201 0.048 DBMET01902 0.233 0.029 DBMET01903 | DBMET01903 | |
| 0.04 | 0.59 | 0.265 | Superoxide dismutase inhibitor | 0.228 0.091 DBMET01902 0.265 0.066 DBMET01903 | DBMET01903 | |
| 0.004 | 0.564 | 0.127 | Dihydroorotate dehydrogenase inhibitor | 0.091 0.014 DBMET01902 0.127 0.006 DBMET01903 | DBMET01903 | |
| 0.006 | 0.568 | 0.05 | Lysophosphatidic acid 3 receptor antagonist | 0.05 0.035 DBMET01903 | DBMET01903 | |
| 0.007 | 0.569 | 0.176 | Porphobilinogen synthase inhibitor | 0.101 0.035 DBMET01902 0.176 0.015 DBMET01903 | DBMET01903 | |
| 0.006 | 0.575 | 0.055 | Dihydroorotase inhibitor | 0.055 0.02 DBMET01902 0.05 0.024 DBMET01903 | DBMET01902 | |
| 0.02 | 0.59 | 0.115 | Carbonic anhydrase III inhibitor | 0.091 0.073 DBMET01902 0.115 0.048 DBMET01903 | DBMET01903 | |
| 0.016 | 0.585 | 0.087 | Aminopeptidase B inhibitor | 0.087 0.075 DBMET01903 | DBMET01903 | |
| 0.015 | 0.586 | 0.07 | Glutamate dehydrogenase inhibitor | 0.07 0.056 DBMET01903 | DBMET01903 | |
| 0.003 | 0.574 | 0.068 | Retinoid X alpha receptor agonist | 0.068 0.009 DBMET01903 | DBMET01903 | |
| 0.004 | 0.579 | 0.037 | Nicotinic acid receptor agonist | 0.037 0.024 DBMET01902 | DBMET01902 | |
| 0.015 | 0.595 | 0.132 | GABA C receptor rho-1 antagonist | 0.095 0.07 DBMET01902 0.132 0.031 DBMET01903 | DBMET01903 | |
| 0.007 | 0.593 | 0.119 | 5-Lipoxygenase inhibitor | 0.119 0.051 DBMET01903 | DBMET01903 | |
| 0.03 | 0.619 | 0.186 | Hexokinase inhibitor | 0.142 0.089 DBMET01902 0.186 0.045 DBMET01903 | DBMET01903 | |
| 0.002 | 0.597 | 0.036 | Dihydropteroate synthase inhibitor | 0.036 0.033 DBMET01903 | DBMET01903 | |
| 0.011 | 0.626 | 0.11 | GABA C receptor antagonist | 0.098 0.082 DBMET01902 0.11 0.064 DBMET01903 | DBMET01903 | |
| 0.011 | 0.628 | 0.092 | Creatine kinase inhibitor | 0.092 0.069 DBMET01903 | DBMET01903 | |
| 0.005 | 0.625 | 0.118 | CXC chemokine receptor antagonist | 0.077 0.041 DBMET01901 0.118 0.018 DBMET01900 | DBMET01900 | |
| 0.006 | 0.643 | 0.05 | Aconitate hydratase inhibitor | 0.05 0.038 DBMET01903 | DBMET01903 | |
| 0.014 | 0.659 | 0.233 | Lipoxygenase inhibitor | 0.233 0.112 DBMET01903 | DBMET01903 | |
| 0.019 | 0.665 | 0.091 | Carbonic anhydrase XV inhibitor | 0.091 0.082 DBMET01903 | DBMET01903 | |
| 0.005 | 0.652 | 0.032 | Glutamate (mGluR4) agonist | 0.032 0.029 DBMET01903 | DBMET01903 | |
| 0.047 | 0.698 | 0.365 | 5 Hydroxytryptamine release inhibitor | 0.262 0.212 DBMET01902 0.365 0.103 DBMET01903 | DBMET01903 | |
| 0.036 | 0.697 | 0.29 | Cyclophilin D inhibitor | 0.29 0.172 DBMET01900 | DBMET01900 | |
| 0.006 | 0.682 | 0.124 | Alcohol dehydrogenase inhibitor | 0.124 0.032 DBMET01903 | DBMET01903 | |
| 0.009 | 0.693 | 0.114 | Ferrochelatase inhibitor | 0.089 0.084 DBMET01902 0.114 0.058 DBMET01903 | DBMET01903 | |
| 0.004 | 0.689 | 0.076 | Glutamate decarboxylase inhibitor | 0.076 0.048 DBMET01903 | DBMET01903 | |
| 0.022 | 0.717 | 0.241 | Histone acetyltransferase inhibitor | 0.241 0.029 DBMET01903 | DBMET01903 | |
| 0.005 | 0.706 | 0.132 | Glycogen synthase kinase-3 alpha inhibitor | 0.132 0.077 DBMET01903 | DBMET01903 | |
| 0.034 | 0.755 | 0.229 | GABA C receptor rho-3 antagonist | 0.229 0.174 DBMET01903 | DBMET01903 | |
| 0.007 | 0.729 | 0.211 | Pyruvate kinase inhibitor | 0.211 0.075 DBMET01903 | DBMET01903 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |